Correction: Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1.

Correction: Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1.

Bibliographic Details
Main Authors:	Iliyana Mikell, D. Noah Sather, Spyros A. Kalams, Marcus Altfeld, Galit Alter, Leonidas Stamatatos
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-03-01
Series:	PLoS Pathogens
Online Access:	http://europepmc.org/articles/PMC3047587

Similar Items

Characteristics of the earliest cross-neutralizing antibody response to HIV-1.
by: Iliyana Mikell, et al.
Published: (2011-01-01)

Evolution of cross-neutralizing antibody specificities to the CD4-BS and the carbohydrate cloak of the HIV Env in an HIV-1-infected subject.
by: Iliyana Mikell, et al.
Published: (2012-01-01)

Soluble HIV-1 envelope immunogens derived from an elite neutralizer elicit cross-reactive V1V2 antibodies and low potency neutralizing antibodies.
by: Sara Carbonetti, et al.
Published: (2014-01-01)

Correction: Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
Published: (2011-03-01)

Differences in Allelic Frequency and CDRH3 Region Limit the Engagement of HIV Env Immunogens by Putative VRC01 Neutralizing Antibody Precursors
by: Christina Yacoob, et al.
Published: (2016-11-01)

Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth.
by: Valentine U Chukwuma, et al.
Published: (2018-01-01)

P09-06. HIV-1 escape from broadly neutralizing anti-CD4 binding site NAbs during HIV-1 infection
by: Stamatatos L, et al.
Published: (2009-10-01)

P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens
by: Stamatatos L, et al.
Published: (2009-10-01)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
by: Celia C LaBranche, et al.
Published: (2019-03-01)

Correction: The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies.
by: Devin Sok, et al.
Published: (2013-12-01)

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
by: Carolyn M. Boudreau, et al.
Published: (2019-03-01)

Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth
by: Deniz Cizmeci, et al.
Published: (2021-04-01)

Correction: The Earliest Matches
Published: (2012-01-01)

Correction: The Earliest Matches.
by: Naama Goren-Inbar, et al.
Published: (2012-01-01)

P05-09. 4e10 epitope-scaffolds mimic the antibody-bound epitope conformation and block neutralization by sera from rare HIV+ individuals
by: Strong R, et al.
Published: (2009-10-01)

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection
by: Archary, Derseree, et al.
Published: (2014)

Correction: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs.
by: Sam Hoot, et al.
Published: (2013-07-01)

Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
by: K. Rachael Parks, et al.
Published: (2019-12-01)

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
by: Sok, Devin, et al.
Published: (2014)

Antibody neutralization of HIV-1.
by: Poignard, P, et al.
Published: (1996)

Neutralization of HIV-1 by antibody.
by: Sattentau, Q
Published: (1996)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
by: Celia C LaBranche, et al.
Published: (2018-11-01)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
by: Labranche, CC, et al.
Published: (2018)

Plasma CXCL13 but Not B Cell Frequencies in Acute HIV Infection Predicts Emergence of Cross-Neutralizing Antibodies
by: Jenniffer M. Mabuka, et al.
Published: (2017-09-01)

A cross-neutralizing antibody between HIV-1 and influenza virus.
by: Chang-Chun D Lee, et al.
Published: (2021-03-01)

Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing.
by: Michael Humbert, et al.
Published: (2008-01-01)

Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection
by: M. Muenchhoff, et al.
Published: (2020-12-01)

NK Cells in HIV Disease
by: Scully, Eileen, et al.
Published: (2017)

HIV-1-Specific T Cell Function During Acute HIV-1 Infection
by: Altfeld Marcus
Published: (2005-12-01)

Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
by: Shilei Ding, et al.
Published: (2020-10-01)

Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
by: Andrew T. McGuire, et al.
Published: (2016-02-01)

B cell clonal lineage alterations upon recombinant HIV-1 envelope immunization of rhesus macaques.
by: Christina Yacoob, et al.
Published: (2018-06-01)

Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma.
by: Nitesh Mishra, et al.
Published: (2021-09-01)

P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
by: Reinherz EL, et al.
Published: (2009-10-01)

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
by: Archary, D, et al.
Published: (2012)

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection
by: Archary, D, et al.
Published: (2012)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
by: Archary, D, et al.
Published: (2012)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
by: Archary D, et al.
Published: (2012-09-01)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
by: Elise Landais, et al.
Published: (2018-09-01)

Neutralization-enhancing RF antibodies for HIV vaccines
by: Konstantin V Suslov
Published: (2014-12-01)